Bank of New York Mellon’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-142,509
| Closed | -$13.8M | – | 4270 |
|
|
2019
Q3 | $13.8M | Sell |
142,509
-1,983
| -1% | -$192K | ﹤0.01% | 1746 |
|
|
2019
Q2 | $14.8M | Buy |
144,492
+2,690
| +2% | +$275K | ﹤0.01% | 1731 |
|
|
2019
Q1 | $16.1M | Sell |
141,802
-207
| -0.1% | -$23.6K | ﹤0.01% | 1683 |
|
|
2018
Q4 | $5.56M | Sell |
142,009
-373
| -0.3% | -$14.6K | ﹤0.01% | 2222 |
|
|
2018
Q3 | $7.77M | Buy |
142,382
+1,015
| +0.7% | +$55.4K | ﹤0.01% | 2174 |
|
|
2018
Q2 | $11.7M | Buy |
141,367
+6,613
| +5% | +$547K | ﹤0.01% | 1935 |
|
|
2018
Q1 | $8.97M | Buy |
134,754
+931
| +0.7% | +$62K | ﹤0.01% | 2031 |
|
|
2017
Q4 | $6.88M | Sell |
133,823
-19,020
| -12% | -$978K | ﹤0.01% | 2199 |
|
|
2017
Q3 | $13.6M | Buy |
152,843
+35,722
| +31% | +$3.19M | ﹤0.01% | 1814 |
|
|
2017
Q2 | $7M | Buy |
117,121
+6,078
| +5% | +$363K | ﹤0.01% | 2153 |
|
|
2017
Q1 | $5.92M | Buy |
111,043
+10,916
| +11% | +$582K | ﹤0.01% | 2245 |
|
|
2016
Q4 | $5M | Buy |
100,127
+5,843
| +6% | +$292K | ﹤0.01% | 2312 |
|
|
2016
Q3 | $5.66M | Buy |
94,284
+11,061
| +13% | +$664K | ﹤0.01% | 2184 |
|
|
2016
Q2 | $4.26M | Buy |
83,223
+17,321
| +26% | +$886K | ﹤0.01% | 2287 |
|
|
2016
Q1 | $1.95M | Buy |
65,902
+8,934
| +16% | +$264K | ﹤0.01% | 2674 |
|
|
2015
Q4 | $2.58M | Buy |
56,968
+16,093
| +39% | +$729K | ﹤0.01% | 2560 |
|
|
2015
Q3 | $1.71M | Sell |
40,875
-9,878
| -19% | -$412K | ﹤0.01% | 2824 |
|
|
2015
Q2 | $3.06M | Buy |
50,753
+18,722
| +58% | +$1.13M | ﹤0.01% | 2648 |
|
|
2015
Q1 | $2.48M | Buy |
+32,031
| New | +$2.48M | ﹤0.01% | 2711 |
|